Helix BioMedix Inc HXBM:OTCPK

RT Quote | Exchange | USD
Last | 12/28/21 EDT
12.00UNCH (UNCH)
52 week range
12.00 - 24.80
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close12.00
  • 52 Week High24.80
  • 52 Week High Date08/27/21
  • 52 Week Low12.00
  • 52 Week Low Date12/28/21

Key Stats

  • Market Cap2.64M
  • Shares Out220,000.00
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close12.00
  • 52 Week High24.80
  • 52 Week High Date08/27/21
  • 52 Week Low12.00
  • 52 Week Low Date12/28/21
  • Market Cap2.64M
  • Shares Out220,000.00
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-15.59
  • P/E (TTM)-0.77
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-2.329M
  • ROE (TTM)-122.53%
  • Revenue (TTM)2.07M
  • Gross Margin (TTM)68.96%
  • Net Margin (TTM)-125.06%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Helix BioMedix Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Helix BioMedix, Inc. is a biopharmaceutical company. The Company is focused on drug development for treatment of rare dermatological diseases. The Company's research and development (R&D) consists of a proprietary library of patented bioactive peptides based on the body’s innate immunity. The Company is focused on developing HB4208 for treatment of the rare disease Xeroderma Pigmentosum (XP). HB4208 is a polypeptide DNA Damage Response (DDR) enzyme that is based on cellular...
R Beatty
President, Chief Executive Officer, Acting Chief Financial Officer, Director
Robin Carmichael
Chief Operating Officer, Vice President
Address
22121 17th Ave SE Ste 112
Bothell, WA
98021-7404
United States